Maravai LifeSciences Sees FY24 Revenue $265M-$285M Vs $261.033M Est.
Portfolio Pulse from Benzinga Newsdesk
Maravai LifeSciences projects its FY24 revenue to be between $265M and $285M, surpassing the estimated $261.033M.
February 22, 2024 | 9:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Maravai LifeSciences anticipates FY24 revenue to exceed expectations, projecting $265M-$285M against a $261.033M estimate.
Maravai LifeSciences' projection of higher-than-expected revenue for FY24 suggests strong business performance and growth prospects. This positive outlook is likely to instill investor confidence and could lead to an uptick in MRVI's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100